treats Deafness, Glaucoma, Diabetic retinopathy, Alcoholism, Menopausal symptoms, Cardiovascular disease / angina, and Diabetes
TraditionWARNING: DISCLAIMER: The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.
Allergic rhinitis, anti- inflammatory, antioxidant, antithrombotic (blood clots), cancer, cerebral ischemia (a lack of adequate blood flow to the brain), circulation, cirrhosis (liver disease), colds, diarrhea, dysentery (severe diarrhea), elimination of toxins, encephalitis (brain infection), estrogenic effects, fever, gastritis (inflammation of the stomach), gastroenteritis (inflammation of stomach, intestine), hangovers, headaches, hypertension (high blood pressure), influenza, leukemia, macular degeneration (chronic eye disease), measles, menstrual irregularities, migraine, myalgia (muscle pain), reperfusion injury (myocardial, restoration of blood flow), neck stiffness, osteoporosis, pain, Parkinson's disease, pruritus (severe itching), psoriasis (chronic skin disease), pulmonary embolism, sinusitis, sweat stimulation, tinnitus, trauma, urticaria (hives), vasorelaxant (reduces tension of the blood vessel walls).
Adults (over 18 years old)
Several doses of kudzu have been studied. For alcoholism, 1.2 grams kudzu root extract twice daily for one month has been used. For menopausal symptoms, 50 milligrams daily and 100 milligrams daily of Pueraria mirifica once daily for six months has been used. Kudzu powder (containing 100 milligrams isoflavones) dissolved in water once daily for three months has also been used.
Puerarin 400 milligrams daily for ten days has been taken by mouth to improve heart function in patients with chronic cardiac failure. Puerarin 500 milligrams has also been given as an injection daily for two weeks to reduce the size of infarction in patients with acute myocardial infarction (heart attack). Doses between 400- 500 milligrams are typically used to treat diabetes, diabetic retinopathy and unstable angina pectoris (chest pain). Injections should only be given under the guidance of a qualified healthcare professional, including a pharmacist.
Children (under 18 years old)
There is no proven safe or effective dose for kudzu.